Menu

Recent Interviews

Jerre Foo, Corporate Development Executive, Silkroad Nickel

Jerre Foo
Corporate Development Executive | Silkroad Nickel
50 Armenian Street #03-04, 179938 Singapore (SGP)

enquiries@silkroadnickel.com

+65 6327 8971

Silkroad Nickel: 'The course is set for dynamic profit growth.'


Dr. Thomas Gutschlag, CEO, Deutsche Rohstoff AG

Dr. Thomas Gutschlag
CEO | Deutsche Rohstoff AG
Q7, 24, 68161 Mannheim (D)

info@rohstoff.de

+49 621 490 817 0

Interview Deutsche Rohstoff AG: "We can imagine additional investments in the field of electromobility."


Steve Cope, President, CEO and Director, Silver Viper

Steve Cope
President, CEO and Director | Silver Viper
1055 W Hastings St Suite 1130, V6E 2E9 Vancouver (CAN)

info@silverviperminerals.com

+1-604-687-8566

Interview with Silver Viper: Future price drivers and takeover fantasy


22. September 2020 | 09:20 CET

Almonty, BASF, Bayer: where is it worth starting now?

  • Investments
Photo credits: pixabay.com

The start of the week was marked by price losses. In Europe and North America, the leading indices closed in the red. The fear of further effects of the Corona Pandemic has dampened market sentiment. Given that the banknote presses are still running, the breather on the capital markets is again likely to be short-lived. At the time when a vaccine against Covid-19 receives approval, the economy will once again experience an unleashed boom - provided that people can and may want to return to their jobs. Which shares are worthwhile now?

time to read: 2 minutes by Mario Hose


 

Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author


Access in Europe and Asia

The Canadian tungsten producer Almonty Industries operates mines in Portugal and Spain. The company has plans to secure future access to the hardest metal on earth in South Korea. The deposit in South Korea is one of the largest of its kind in the world. The importance of this project for Almonty is therefore significant, as it will enable the company to meet the growing demand for the critical raw material.

State support for supply

One of the largest suppliers of tungsten in the world market is China, which has an almost monopoly-like position. The dependence of the other industrialized countries cannot be denied. However, with increasing prosperity, the demand for tungsten is also increasing in China. For this reason, industry representatives are concerned about the future supply for the market. The German Kreditanstalt für Wiederaufbau (KfW) is helping companies in the sector to secure access. In this context, KfW has also committed USD 75 million in project finance to Almonty so that the Sangdong project in South Korea can be further developed.

Fear of market dominance

According to a survey of US executives, 63% of respondents responding to the main challenges in the raw materials supply chain said that it was detrimental to their business that China controlled too much of the supply. A further 74% said that the greatest threat to their manufacturing business over the next 12 months would be disruptions and restrictions in the supply chain. It is clear that Almonty's work is of increasing importance.

Competitive disadvantage in the US increasing

"It is a dangerous time for U.S. manufacturers to face a limited supply chain of precious and strategic metals that are so important to the industry, businesses, and consumers today," said Lewis Black, CEO of Almonty and continued: "Covid-19 has put unwanted economic pressure on many U.S. manufacturers, in addition to the trade war between China and the U.S., which has already put U.S. industry in price and financial trouble."

Diversification for the portfolio

While Almonty's market value of around CAD 138 million is still low compared to the DAX companies BASF and Bayer, the two large companies are also worth considering an investment. BASF currently has a market capitalization of EUR 46.5 billion and Bayer EUR 52.9 billion. Almonty offers an opportunity to participate in the value creation of critical raw material. The analysts of First Berlin rate the share with a target price of CAD 1.45 as 'buy'.


Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

20. April 2021 | 09:45 CET | by Stefan Feulner

Varta, Sierra Growth, CureVac - Clear signals!

  • Investments

Sometimes, for various reasons, it takes longer before the positive developments of a Company are absorbed by the market and thus provide for price gains. It is currently similar to the precious metal gold, which is still in the consolidation phase. The facts such as national debt, inflation fears and the ultra-loose monetary policy of the central banks speak another clear language.

Read

20. April 2021 | 07:10 CET | by Carsten Mainitz

BioNTech, SunMirror, Steinhoff - Great News!

  • Investments

Shortly before the finish line, the going gets tough again. Many athletes and those who have to really "bite" in the last few meters before a deadline are probably familiar with this feeling. Everyday life in the Corona pandemic is also becoming more exhausting. Now, with BioNTech's announcement that it will double weekly vaccine dose deliveries to around 5.1 million units from the end of May, there may be a breakthrough in achieving herd immunity in Germany in the next few months. It is not only good news for the Company's shareholders but everyone. Below we present two other companies whose shareholders should be very pleased. Let us surprise you!

Read

15. April 2021 | 07:15 CET | by Stefan Feulner

Alibaba, The Place Holdings, CureVac - Great opportunities lie here!

  • Investments

The German vaccination disaster is going into the next round. After the AstraZeneca vaccine's back and forth and the question of whether only younger people, older people or no one should be vaccinated with the vaccine, the American vaccine manufacturer Johnson & Johnson is now experiencing delivery stoppages. The return to "normality" once again seems to be a long way off. Another question to ask yourself. What will future life in the new normal look like in the hard-pressed inner cities?

Read